HALO logo

Halozyme Therapeutics (HALO) Earnings Per Share

Annual EPS

$3.43
+$1.33+63.33%

December 31, 2024

Summary

Performance

1-Year Change

+63.33%

3-Year Change

+25.18%

5-Year Change

+786%

15-Year Change

+662.22%

HALO EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

94.56%
HALO annual earnings per share is higher than 94.56% of companies in Healthcare sector

Analysts Estimate

$4.93
HALO annual earnings per share is currently -30.39% lower than the consensus analysts' forecast

High & Low

All-time High

$3.43
HALO annual earnings per share is currently at an all-time high

3-Year Low

$1.44
HALO annual earnings per share is currently +138.19% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
HALO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
HALO next annual earnings announcement has not yet been scheduled

OtherHALOprofitabilitymetrics:

Annual Revenue

$1.02 B
HALO annual revenue is $1.02 billion

Annual Gross Profit

$855.91 M
HALO annual gross profit is $855.91 million

Annual Operating Profit

$551.48 M
HALO annual operating income is $551.48 million

Annual Net Income

$444.09 M
HALO annual net profit is $444.09 million

Quarterly EPS

$1.06
+$0.01+0.95%

December 31, 2024

Summary

Performance

3-Month Change

+0.95%

1-Year Change

+63.08%

3-Year Change

+73.77%

5-Year Change

+73.77%

HALO Quarterly EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

93.87%
HALO quarterly earnings per share is higher than 93.87% of companies in Healthcare sector

Analysts Estimate

$0.95
HALO quarterly earnings per share is currently +12.09% higher than the consensus analysts' forecast

High & Low

All-time High

$1.48
HALO quarterly earnings per share is currently -28.38% below its historical high of $1.48

3-Year Low

$0.16
HALO quarterly earnings per share is currently +562.50% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
HALO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
HALO next earnings announcement is scheduled for May 7, 2025

OtherHALOprofitabilitymetrics:

Quarterly Revenue

$298.01 M
HALO quarterly revenue is $298.01 million

Quarterly Gross Profit

$255.95 M
HALO quarterly gross profit is $255.95 million

Quarterly Operating Profit

$175.50 M
HALO quarterly operating income is $175.50 million

Quarterly Net Income

$137.01 M
HALO quarterly net profit is $137.01 million

TTM EPS

$3.43
+$0.41+13.58%

December 31, 2024

Summary

Performance

3-Month Change

+13.58%

1-Year Change

+62.56%

3-Year Change

+82.45%

5-Year Change

+82.45%

HALO TTM EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

94.47%
HALO TTM earnings per share is higher than 94.47% of companies in Healthcare sector

Analysts Estimate

$3.78
HALO TTM earnings per share is currently -9.16% lower than the consensus analysts' forecast

High & Low

All-time High

$3.43
HALO TTM earnings per share is currently at an all-time high

3-Year Low

$1.31
HALO TTM earnings per share is currently +161.83% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
HALO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 7, 2025
HALO next earnings announcement is scheduled for May 7, 2025

OtherHALOprofitabilitymetrics:

Annual Revenue

$1.02 B
HALO annual revenue is $1.02 billion

Annual Gross Profit

$855.91 M
HALO annual gross profit is $855.91 million

Annual Operating Profit

$551.48 M
HALO annual operating income is $551.48 million

Annual Net Income

$444.09 M
HALO annual net profit is $444.09 million

EPS Formula

EPS =  
Net Income - Preferred Dividends
Shares Outstanding

Annual EPS

$3.43
HALO annual earnings per share is $3.43

Annual Net Income

$444.09 M
HALO annual net profit is $444.09 million

Shares Outstanding

123.15 M
HALO shares outstanding is 123.15 million

HALO EPS Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+63.3%+63.1%+62.6%
3 y3 years+25.2%+73.8%+82.5%
5 y5 years+786.0%+73.8%+82.5%

HALO EPS Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+138.2%at high+562.5%at high+161.8%
5 y5-yearat high+786.0%-28.4%+541.7%at high+723.6%
alltimeall timeat high+523.5%-28.4%+507.7%at high+468.8%

Halozyme Therapeutics EPS History

DateAnnualQuarterlyTTM
Dec 2024
$3.43(+63.3%)
$1.06(+1.0%)
$3.43(+13.6%)
Sep 2024
-
$1.05(+45.8%)
$3.02(+17.1%)
Jun 2024
-
$0.72(+20.0%)
$2.58(+6.6%)
Mar 2024
-
$0.60(-7.7%)
$2.42(+14.7%)
Dec 2023
$2.10(+45.8%)
$0.65(+6.6%)
$2.11(+12.2%)
Sep 2023
-
$0.61(+8.9%)
$1.88(+9.9%)
Jun 2023
-
$0.56(+93.1%)
$1.71(+30.5%)
Mar 2023
-
$0.29(-31.0%)
$1.31(-9.7%)
Dec 2022
$1.44(-47.4%)
$0.42(-4.5%)
$1.45(-2.7%)
Sep 2022
-
$0.44(+175.0%)
$1.49(-41.1%)
Jun 2022
-
$0.16(-62.8%)
$2.53(-15.4%)
Mar 2022
-
$0.43(-6.5%)
$2.99(+8.7%)
Dec 2021
$2.74(+201.1%)
$0.46(-68.9%)
$2.75(-1.4%)
Sep 2021
-
$1.48(+138.7%)
$2.79(+78.8%)
Jun 2021
-
$0.62(+226.3%)
$1.56(+38.1%)
Mar 2021
-
$0.19(-62.0%)
$1.13(+25.6%)
Dec 2020
$0.91(-282.0%)
$0.50(+100.0%)
$0.90(+462.5%)
Sep 2020
-
$0.25(+31.6%)
$0.16(-161.5%)
Jun 2020
-
$0.19(-575.0%)
-$0.26(-52.7%)
Mar 2020
-
-$0.04(-83.3%)
-$0.55(+10.0%)
Dec 2019
-$0.50(-10.7%)
-$0.24(+41.2%)
-$0.50(+85.2%)
Sep 2019
-
-$0.17(+70.0%)
-$0.27(-6.9%)
Jun 2019
-
-$0.10(-1100.0%)
-$0.29(-17.1%)
Mar 2019
-
$0.01(-200.0%)
-$0.35(-36.4%)
Dec 2018
-$0.56(-224.4%)
-$0.01(-94.7%)
-$0.55(-277.4%)
Sep 2018
-
-$0.19(+18.8%)
$0.31(-40.4%)
Jun 2018
-
-$0.16(-15.8%)
$0.52(+15.6%)
Mar 2018
-
-$0.19(-122.4%)
$0.45(+18.4%)
Dec 2017
$0.45(-155.6%)
$0.85(+4150.0%)
$0.38(-155.9%)
Sep 2017
-
$0.02(-108.7%)
-$0.68(-26.9%)
Jun 2017
-
-$0.23(-11.5%)
-$0.93(+2.2%)
Mar 2017
-
-$0.26(+23.8%)
-$0.91(+12.3%)
Dec 2016
-$0.81(+224.0%)
-$0.21(-8.7%)
-$0.81(+42.1%)
Sep 2016
-
-$0.23(+9.5%)
-$0.57(+7.5%)
Jun 2016
-
-$0.21(+31.3%)
-$0.53(+76.7%)
Mar 2016
-
-$0.16(-633.3%)
-$0.30(+15.4%)
Dec 2015
-$0.25(-55.4%)
$0.03(-115.8%)
-$0.26(-21.2%)
Sep 2015
-
-$0.19(-1050.0%)
-$0.33(+10.0%)
Jun 2015
-
$0.02(-116.7%)
-$0.30(-33.3%)
Mar 2015
-
-$0.12(+200.0%)
-$0.45(-18.2%)
Dec 2014
-$0.56(-24.3%)
-$0.04(-75.0%)
-$0.55(-21.4%)
Sep 2014
-
-$0.16(+23.1%)
-$0.70(-1.4%)
Jun 2014
-
-$0.13(-40.9%)
-$0.71(-9.0%)
Mar 2014
-
-$0.22(+15.8%)
-$0.78(+6.8%)
Dec 2013
-$0.74
-$0.19(+11.8%)
-$0.73(+25.9%)
Sep 2013
-
-$0.17(-15.0%)
-$0.58(-1.7%)
DateAnnualQuarterlyTTM
Jun 2013
-
-$0.20(+17.6%)
-$0.59(+13.5%)
Mar 2013
-
-$0.17(+325.0%)
-$0.52(+6.1%)
Dec 2012
-$0.48(+152.6%)
-$0.04(-77.8%)
-$0.49(-22.2%)
Sep 2012
-
-$0.18(+38.5%)
-$0.63(+57.5%)
Jun 2012
-
-$0.13(-7.1%)
-$0.40(+66.7%)
Mar 2012
-
-$0.14(-22.2%)
-$0.24(+20.0%)
Dec 2011
-$0.19(-66.1%)
-$0.18(-460.0%)
-$0.20(+5.3%)
Sep 2011
-
$0.05(+66.7%)
-$0.19(-48.6%)
Jun 2011
-
$0.03(-130.0%)
-$0.37(-30.2%)
Mar 2011
-
-$0.10(-41.2%)
-$0.53(-5.4%)
Dec 2010
-$0.56(-16.4%)
-$0.17(+30.8%)
-$0.56(+7.7%)
Sep 2010
-
-$0.13(0.0%)
-$0.52(-5.5%)
Jun 2010
-
-$0.13(0.0%)
-$0.55(-12.7%)
Mar 2010
-
-$0.13(0.0%)
-$0.63(-7.4%)
Dec 2009
-$0.67(+9.8%)
-$0.13(-18.8%)
-$0.68(-10.5%)
Sep 2009
-
-$0.16(-23.8%)
-$0.76(+2.7%)
Jun 2009
-
-$0.21(+16.7%)
-$0.74(+10.4%)
Mar 2009
-
-$0.18(-14.3%)
-$0.67(+8.1%)
Dec 2008
-$0.61(+90.6%)
-$0.21(+50.0%)
-$0.62(+19.2%)
Sep 2008
-
-$0.14(0.0%)
-$0.52(+10.6%)
Jun 2008
-
-$0.14(+7.7%)
-$0.47(+17.5%)
Mar 2008
-
-$0.13(+18.2%)
-$0.40(+25.0%)
Dec 2007
-$0.32(+33.3%)
-$0.11(+22.2%)
-$0.32(+14.3%)
Sep 2007
-
-$0.09(+28.6%)
-$0.28(+12.0%)
Jun 2007
-
-$0.07(+40.0%)
-$0.25(+8.7%)
Mar 2007
-
-$0.05(-28.6%)
-$0.23(-4.2%)
Dec 2006
-$0.24(-7.7%)
-$0.07(+16.7%)
-$0.24(+4.3%)
Sep 2006
-
-$0.06(+20.0%)
-$0.23(-4.2%)
Jun 2006
-
-$0.05(-16.7%)
-$0.24(-4.0%)
Mar 2006
-
-$0.06(0.0%)
-$0.25(0.0%)
Dec 2005
-$0.26(0.0%)
-$0.06(-14.3%)
-$0.25(+4.2%)
Sep 2005
-
-$0.07(+16.7%)
-$0.24(-4.0%)
Jun 2005
-
-$0.06(0.0%)
-$0.25(+4.2%)
Mar 2005
-
-$0.06(+20.0%)
-$0.24(-7.7%)
Dec 2004
-$0.26(-16.1%)
-$0.05(-37.5%)
-$0.26(-31.6%)
Sep 2004
-
-$0.08(+60.0%)
-$0.38(+8.6%)
Jun 2004
-
-$0.05(-37.5%)
-$0.35(0.0%)
Mar 2004
-
-$0.08(-52.9%)
-$0.35(+16.7%)
Dec 2003
-$0.31(+24.0%)
-$0.17(+240.0%)
-$0.30(+2.2%)
Sep 2003
-
-$0.05(0.0%)
-$0.29(+20.5%)
Jun 2003
-
-$0.05(+66.7%)
-$0.24(+25.9%)
Mar 2003
-
-$0.03(-81.6%)
-$0.19(+18.4%)
Dec 2002
-$0.25(<-9900.0%)
-$0.16(<-9900.0%)
-$0.16(<-9900.0%)
Sep 2002
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2002
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2002
-
$0.00
$0.00
Dec 2001
$0.00
-
-

FAQ

  • What is Halozyme Therapeutics annual earnings per share?
  • What is the all time high annual EPS for Halozyme Therapeutics?
  • What is Halozyme Therapeutics annual EPS year-on-year change?
  • What is Halozyme Therapeutics quarterly earnings per share?
  • What is the all time high quarterly EPS for Halozyme Therapeutics?
  • What is Halozyme Therapeutics quarterly EPS year-on-year change?
  • What is Halozyme Therapeutics TTM earnings per share?
  • What is the all time high TTM EPS for Halozyme Therapeutics?
  • What is Halozyme Therapeutics TTM EPS year-on-year change?

What is Halozyme Therapeutics annual earnings per share?

The current annual EPS of HALO is $3.43

What is the all time high annual EPS for Halozyme Therapeutics?

Halozyme Therapeutics all-time high annual earnings per share is $3.43

What is Halozyme Therapeutics annual EPS year-on-year change?

Over the past year, HALO annual earnings per share has changed by +$1.33 (+63.33%)

What is Halozyme Therapeutics quarterly earnings per share?

The current quarterly EPS of HALO is $1.06

What is the all time high quarterly EPS for Halozyme Therapeutics?

Halozyme Therapeutics all-time high quarterly earnings per share is $1.48

What is Halozyme Therapeutics quarterly EPS year-on-year change?

Over the past year, HALO quarterly earnings per share has changed by +$0.41 (+63.08%)

What is Halozyme Therapeutics TTM earnings per share?

The current TTM EPS of HALO is $3.43

What is the all time high TTM EPS for Halozyme Therapeutics?

Halozyme Therapeutics all-time high TTM earnings per share is $3.43

What is Halozyme Therapeutics TTM EPS year-on-year change?

Over the past year, HALO TTM earnings per share has changed by +$1.32 (+62.56%)